{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-042975","form_type":"8-K","ticker":"IBO","cik":"0001834105","company_name":"IMPACT BIOMEDICAL INC.","filed_at":"2026-09-16T22:05:39+00:00","discovered_at":"2026-09-17T10:05:00.790431+00:00","generated_at":"2026-09-17T10:06:11.564002+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Impact Biomedical: Zoar files Form F-4 for merger; closing still subject to SEC, shareholder vote, listing","bullets":["Zoar Limited filed Form F-4 with SEC on Sept 10, 2026 for proposed merger with Impact Biomedical (NYSE: IBO).","Combined company to focus on active pharmaceutical ingredients and intermediates for therapeutic areas.","Completion requires SEC effectiveness, Impact stockholder approval, and NYSE American listing of PubCo ordinary shares.","Preliminary proxy statement/prospectus included; definitive version to be mailed after effectiveness."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-042975","json":"https://secwatch.observer/filing/0001493152-26-042975.json","markdown":"https://secwatch.observer/filing/0001493152-26-042975.md","text":"https://secwatch.observer/filing/0001493152-26-042975.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1834105/000149315226042975/0001493152-26-042975-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1834105/000149315226042975/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-17T10:06:11.564002+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}